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Summary 
 
Chronic metabolic inflammation is a key feature of obesity, insulin resistance and 
diabetes, although the initiation and propagation mechanisms of metaflammation are not 
fully established, particularly in the adipose tissue. Here we show that in adipocytes, 
altered regulation of the Ca2+ channel inositol triphosphate receptor (IP3Rs) is a key, 
adipocyte-intrinsic, event involved in the emergence and propagation of inflammatory 
signaling and the resulting insulin resistance. Inflammation, either induced by cytokine 
exposure in vitro or by obesity in vivo lead to increased expression and activity of IP3Rs 
in adipocytes in a JNK-dependent manner. This results in increased cytosolic Ca2+ and 
impaired insulin action. In mice, adipocyte-specific loss of IP3R1/2 protected against 
adipose tissue inflammation and insulin resistance despite significant diet-induced weight 
gain. Thus, this work reveals that IP3R over-activation and the resulting increase in 
cytosolic Ca2+ is a key link between obesity, inflammation and insulin resistance, and 
suggests that approaches to target adipocyte Ca2+ homeostasis may offer new 
therapeutic opportunities against metabolic diseases, especially since GWAS studies 
also implicate this locus in human obesity. 
 
Key words: Adipocyte, Adipose tissue, Obesity, Inflammation, Calcium, Insulin action  
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Introduction: 
 
The white adipose tissue (WAT) is composed of adipocytes, stromal cells, and immune 
cells and has potent energy storage, disposal, and endocrine activity, which are critical 
for the function and survival of the organism(1–4). It is well established that nutrient 
excess and obesity impose chronic pressure and stress on both the storage and 
endocrine functions of WAT. During chronic overnutrition, adipocytes become 
increasingly enlarged and dysfunctional and are not able to buffer nutrients effectively, 
resulting in intracellular stress, recruitment of immune cells, and abnormal production and 
secretion of inflammatory molecules(1–5). Over time, this unfavorable situation ultimately 
results in tissue dysfunction and damage, systemic metabolic failure including insulin 
resistance, dyslipidemia, and metabolic disease.  
 
Although the central role of WAT dysfunction in the development of metabolic diseases 
is well recognized, important questions remain unanswered regarding the mechanisms 
associated with the emergence and propagation of inflammation in WAT. For example, 
the specific signals that determine the transition of adipocytes from a healthy to a 
dysfunctional phenotype during nutritional stress have not been identified, nor it is fully 
understood how metabolic inflammation is triggered and coupled to metabolic 
deterioration. At the cellular level, nutrient excess and the expansion of adipocytes leads 
to organelle stress, particularly in the endoplasmic reticulum (ER). Impaired ER function 
in the adipocytes is associated with unresolved ER unfolded protein response (UPR), in 
both mice and humans. However, how ER dysfunction is coupled to WAT inflammation 
and deterioration is not defined. In fact, in adipocytes, contrary to results in other 
metabolic cells such as hepatocytes, loss of function of key UPR regulators such as 
XBP1(6) or ATF6 (unpublished) did not affect adipose tissue formation and function under 
homeostatic metabolic conditions and does not impact systemic metabolism. Thus, ER 
dysfunction in adipocyte and its impact in cell and systemic metabolism seems to present 
unique features(7–11). 
 
Interestingly, studies performed in Drosophila melanogaster show that alterations in 
mechanisms that control ER Ca2+ homeostasis such as loss of function of the IP3R, the 
ER channel responsible for Ca2+ release from ER to the cytosol, leads to obesity and 
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altered lipid metabolism(12). Additionally, loss of function of another key mechanism that 
control ER and cytosolic Ca2+  levels,  the Store Operated Ca2+ Entry (SOCE) in the fat 
body leads to marked lipid accumulation and obesity in the fly(13). Loss of function of 
SOCE in adipocytes in vitro also leads to alterations in lipid mobilization(14). Interestingly, 
human GWAS studies have shown that an ITPR polymorphism is associated with 
increased body-mass index, fat mass(15) and waist-to-hip ratio(16) but not metabolic 
complications and genotype-phenotype causality has yet to be established.   
 
These studies raise the possibility that regulation of intracellular Ca2+ homeostasis may 
be a key mechanism for adipose tissue metabolism. However, whether the regulation of 
ER Ca2+ handling has any impact on adipocyte organelle function or metabolic and 
inflammatory regulation in mammals have never been explored. Actually, the impact of 
intracellular Ca2+ homeostasis for adipocyte metabolism in general is a largely unexplored 
area.  
 
In the present study, we identified a critical role for IP3Rs and intracellular Ca2+ 
homeostasis as key drivers of adipocyte stress and adipose tissue inflammation. Through 
a series of in vitro and in vivo experiments, we demonstrated that IP3R abundance and 
activity in adipocytes are modulated by inflammatory cytokine exposure in vitro and by 
high fat diet-induced inflammation in vivo in a mechanism dependent of the kinase JNK. 
Experimental downregulation of IP3R isoforms in adipocytes decreased inflammatory 
signaling and metabolic dysfunction in vitro and in vivo, thus demonstrating that regulation 
of Ca2+ homeostasis in adipocytes is a key signal linking metabolic stress to inflammation 
and metabolic deterioration in obesity. 
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Results 
 
Inflammation activates IP3R and CaMKII phosphorylation through JNK 
 
In order to gain insight into a possible role of intracellular Ca2+ regulation in adipocyte 
dysfunction induced by inflammatory and metabolic stress, we first used an in vitro system 
where we exposed differentiated 3T3-L1 adipocytes to a low dose of TNF-a, a pro-
inflammatory cytokine uniformly increased in both mouse and human obesity(1). Addition 
of TNFa to 3T3-L1 cells led to acute elevation of cytosolic Ca2+ (Figure 1A). We then 
exposed 3T3-L1 cells to TNFa for 6 and 24 hours and assessed the ER Ca2+ content in 
those cells by stimulating ER Ca2+ release with the purinergic receptor agonist ATP. 
Addition of ATP in the absence of extracellular Ca2+ lead to decreased cytosolic Ca2+ 
peak in cells previously treated with TNFa for 6h (Figure 1B) and 24h (Supp Figure 1A), 
suggesting that the TNFa preincubation had already depleted ER Ca2+ by shuttling it into 
the cytoplasm. Consistent with the Ca2+ imaging, adipocytes treated with TNFa presented 
higher CaMKII phosphorylation (Figure 1C). Next, we asked whether changes in 
adipocyte Ca2+ dynamics upon TNFa treatment were related to alterations of ER Ca2+ 
release. ER Ca2+ release is coordinated by the action of the IP3Rs and Ryanodine 
receptors (RyaRs). Upon detecting the predominant presence of IP3Rs compared to 
RyaRs in adipocytes and adipose tissue (Supp Figure 1B and 1C), we focused on IP3Rs 
to explore the adipocyte Ca2+ homeostasis and its functional impact on metabolism. As 
shown in Figure 1D and Supp Figure 1D, treatment of adipocytes with TNFa for 6, 12, or 
24 hours led to a marked increase in IP3R1 phosphorylation (Ser1756), an indicator of 
an open channel activity. The increased IP3R1 phosphorylation was also observed after 
TNFa treatment for longer periods of time up to 4 days (96 hours) (Figure 1F). Thus, 
TNFa induces elevation in cytosolic Ca2+ at least in part by modulating IP3R activity.  
 
We then investigated the mechanism through which TNFa affects IP3R expression and 
phosphorylation in adipocytes. Given that JNK is a key inflammatory kinase downstream 
of inflammatory cytokines involved in metabolic homeostasis(17–19), we tested whether 
JNK mediates the effects of TNFa on IP3R abundance and phosphorylation in 
adipocytes. For that, we transfected differentiated 3T3-L1 cells with siRNAs against JNK1 
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and JNK2 or a scrambled siRNA (control) followed by treatment with TNFa for 6, 12 or 
96h (4 days). Interestingly, suppression of JNK1/2 lead to reduction in IP3R expression 
and inhibited TNFa-induced IP3R phosphorylation (Figure 1E and F and Supp Figure 
1E). Additionally, we observed that the induction of CaMKII phosphorylation triggered by 
TNFa in control cells was completely abolished in the absence of JNK1/2 in the 3T3-L1 
adipocytes (Figure 1G and 1H). Altogether, these data reveal that activation of 
inflammatory signaling by TNFa in adipocytes leads to alterations in ER Ca2+release and 
cytosolic Ca2+ levels, which leads to activation of Ca2+ dependent protein kinase CaMKII, 
a process downstream of the protein kinase JNK.   
 
IP3R derived Ca2+ release is key for inflammatory and metabolic actions of TNF-a 
in adipocytes. 
 
Next we tested whether IP3R-induced Ca2+ release is involved in the inflammatory and 
metabolic actions of TNFa on adipocytes. For that we performed siRNA-induced 
knockdown of IP3R1/2/3 in differentiated 3T3-L1 cells. As shown in Figure 2A and Supp 
Figure 2A, this approach efficiently decreased IP3R1/2/3 expression. Additionally, it 
significantly inhibited ER-driven Ca2+ release stimulated by ATP (Figure 2B). We did not 
observe any difference in ATP-stimulated cytosolic Ca2+ elevation between the 
downregulation of IP3R1/2 or IP3R1/2/3, thus in the following experiments we continued 
with combined downregulation of IP3R1/2.  
 
As shown in Figure 2C, TNFa treatment for 6h led to a marked upregulation in the 
expression of pro-inflammatory cytokines and chemokines such as CCL2, CCL5, and 
CCL8, and inflammatory molecules such as iNOS, TNFa itself, and FasL receptor in 
control adipocytes expressing scrambled (SCR) siRNA. Strikingly, the inflammatory 
activity of TNFa was markedly diminished in adipocytes where IP3R1/2 were 
downregulated (Figure 2C). To evaluate whether these effects resulted from changes in 
ER or cytosolic Ca2+ levels upon TNFa exposure, we treated 3T3-L1 cells with BAPTA-
AM, a cytosolic Ca2+ chelator. BAPTA-AM co-treatment for 6h also significantly reduced 
TNFa-induced expression of chemokines and inflammatory molecules (Figure 2D and 
Supp Figure 2B). These data indicate a robust role for IP3Rs in the regulation of TNFa-
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driven inflammation in adipocytes and provide strong evidence that regulation of cytosolic 
Ca2+ signals have a potent action on inflammatory activity in adipocytes. 
 
It is well known that in adipocytes, chronic low-grade TNFa treatment promotes insulin 
resistance by a crosstalk between inflammatory and insulin signaling(5, 20, 21). We 
therefore asked whether decreasing IP3R activity by IP3R1/2 knockdown could prevent 
TNFa-induced insulin resistance in adipocytes. A low-dose TNFa treatment induced 
marked insulin resistance in control adipocytes, as evaluated by insulin stimulation of 
insulin receptor (IR) phosphorylation (Figure 2E). Strikingly, the inhibitory effect of TNFa 
on insulin signaling was abolished in cells lacking IP3Rs 1/2 (Figure 2E). Similar effects 
were observed in 3T3-L1 cells co-treated with BAPTA-AM and TNFa for 72 hours (Supp 
Figure 2C) on AKT phosphorylation, indicating that elevation in cytosolic Ca2+ underlies 
both the inflammatory and metabolic activity of TNFa.   
 
Obesity leads to increased IP3R content and activity in adipose tissue   
 
We next explored the potential role of IP3Rs in adipose tissue dysfunction in vivo and in 
obesity. For that, we first examined the impact of obesity on the expression levels of all 
three IP3R isoforms in epididymal white adipose tissue lysates (eWAT). As shown in 
Figure 3A and Supp Figure 3A, the protein and mRNA expression levels of IP3R1-3 were 
markedly upregulated in mice fed a high-fat diet (HFD). Along with higher expression, 
obesity led to enhanced IP3R1 phosphorylation (Ser1756) (Figure 3A). Because the 
eWAT derived from obese animals contains large number of immune cells, we asked 
whether the presence of IP3R channels reflected expression in infiltrating cells or is 
intrinsic to adipocytes. To address this possibility, we fractionated the adipose tissue from 
lean (low-fat diet) and HFD fed mice in order to separate the stromal vascular fraction 
(SVF) from the buoyant adipocyte layer. Examination of adiponectin as a specific 
adipocyte marker confirmed the validity of the fractionation (Supp Figure 3B). As shown 
in Figure 3B and C, the increased expression of IP3R1/2 in HFD-fed mice was derived 
from the adipocytes, with no significant differences detected in the SVF fraction. We 
additionally evaluated the expression of IP3Rs in epididymal adipose tissue derived from 
a genetic model of obesity, the leptin-deficient mice (ob/ob). Similar to the profile 
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observed in HFD, eWAT derived from ob/ob mice also presented strikingly higher 
expression of IP3R1 and IP3R2 but no significant differences in IP3R3 content (Figure 
3D). To determine whether the increased quantity and activity of IP3Rs in adipocytes 
affects cytosolic Ca2+ levels, we measured the phosphorylation status of CaMKII as a 
proxy for cytosolic Ca2+ (22, 23). We were not able to obtain consistent reads when trying 
to measure cytosolic Ca2+ levels in adipose tissue in vivo with the available Ca2+ imaging 
reporters. As shown in Figure 3E, in mice with both dietary (HFD, upper panel) and 
genetic (lower panel) obesity, phosphorylation of CaMKII in eWAT was significantly 
elevated compared with their lean counterparts. These data strongly support that obesity 
leads to altered Ca2+ homeostasis in adipocytes, at least in part, as a result of higher 
activity of the IP3Rs. 
 
In our experiments with cultured adipocytes, we found that enhanced IP3R expression 
and activity upon TNFa treatment was dependent on the presence of JNK1/2. It is critical 
to examine this paradigm in vivo, in the adipose tissue. Hence, we measured IP3R 
expression and phosphorylation levels in eWAT derived from mice with adipocyte-specific 
loss of both JNK1/2. As shown in Figure 3F and Supp Figure 3C and 3D, total and 
phosphorylated IP3R1 are significantly decreased in eWAT from JNK1/2 deficient mice 
maintained on HFD for 16 weeks. IP3R1 and IP3R2 downregulation in mice with 
adipocyte-specific JNK1/2-deficiency was also observed at mRNA levels (Supp Figure 
3E). Interestingly, we also determined that the increased phosphorylation of CaMKII 
promoted by HFD was diminished in the eWAT from mice deficient in JNK1/2 in 
adipocytes (Figure 3F). These results strongly support a novel and previously 
unrecognized  role for JNK signaling in modulating IP3R abundance and activity in vitro 
and in vivo and also suggests that the increased IP3Rs expression levels detected in 
obese adipose tissue is likely a consequence of an inflammatory activation of JNK and 
serves to integrate critical mechanistic nodes linking obesity and adipose tissue 
inflammation in vivo. 
 
Loss of IP3R1/2 in adipose tissue protects from high fat diet induced inflammation. 
 
To investigate the impact of IP3Rs in adipocyte tissue metabolism in vivo, we generated 
mice with adipocyte-specific loss of function of IP3R1 and 2 (IP3R1/2AdpCre) by crossing 
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mice with IP3R1 and IP3R2 (IP3R1/2) floxed alleles with mice expressing Cre 
recombinase under the control of Adiponectin promoter (Adp-Cre) (Supp Figure 4A). 
Expression of Cre recombinase in adipocytes from IP3R1/2fl/fl significantly decreased 
IP3R1 and 2 protein and mRNA levels as shown in multiple depots, with no significant 
differences in the expression level of IP3R3 (Figure 4A and Supp Figure 4B and C). We 
then evaluated the impact of adipose tissue specific IP3R1/2 loss of function on body 
weight gain and energy expenditure in mice fed a low-fat diet (LFD) or 60% high fat-diet 
(HFD). As shown in Supp Figure 4D, on a LFD, body weight gain between genotypes was 
indistinguishable. However, after 12 weeks on HFD the body weight gain between the 
groups diverged, and by 16 weeks, IP3R1/2AdpCre mice were 15-20% heavier than control 
mice (Figure 4B). DEXA analysis determined that the difference in body weight at 16 
weeks of HFD was largely due to higher fat mass accumulation in IP3R1/2AdpCre mice, 
and no differences were observed in lean mass between the genotypes (Figure 4C). 
IP3R1/2AdpCre mice also showed a tendency for decreased VO2 and VCO2 (Supp Figure 
4E and F), especially after the addition of the b3-agonist CL-316,243. No differences in 
body weight or food intake were observed at this time point (Supp Figure 4G and H). 
Although intracellular Ca2+ regulation can influence lipolysis, we did not see any significant 
differences in basal and isoproterenol (Iso) stimulated lipolysis in these mice 
(Supplemental Figure 4I and J). These data indicate that IP3R1/2-deficiency leads to 
susceptibility to obesity and increased fat mass, similar to what has been observed in 
fruit-flies(12) and in GWAS studies(15, 16). 
 
We next examined the effect of IP3R1/2 downregulation on adipose tissue inflammation 
and stress. In mice fed with a LFD, there were no differences between genotypes in the 
inflammatory status of WAT (Supp Figure 5A). However, obese IP3R1/2AdpCre mice were 
markedly protected from eWAT immune infiltration induced by 8-9 weeks of HFD feeding 
(Figure 4D and Supp Figure 5B), a time when the body weights of both genotypes were 
similar. In addition, the expression of inflammatory molecules CCL1,5,6, CXCL10, F4/80 
and SAA3 were significantly reduced in eWAT tissues derived from IP3R1/2AdpCre 
compared to controls (Figure 4E and Supp Figure 5C). Liver steatosis was also 
significantly decreased in IP3R1/2AdpCre mice compared with controls (Supp Figure 5D). 
We then investigated the impact of IP3R1/2 loss on high-fat diet induced phosphorylation 
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of CaMKII and of stress kinases downstream of inflammation such as JNK, p38, pERK1/2. 
As shown in Figure 4F, IP3R1/2 loss of function in adipose tissue lead to significantly 
decreased levels of pCaMKII, suggesting that deletion of IP3R1/2 channels resulted in 
decreased adipocyte cytosolic Ca2+ levels in vivo. Additionally, we detected that loss of 
IP3R1/2 also significantly inhibited phosphorylation of p38 (Figure 4F) and ERK (supp 
Figure 5E) with no significant effect difference on phosphorylation of JNK (supp Figure 
5E). Notably, this protection from inflammatory stress preceded the development of body 
weight differences between the groups (Figure 4B). At the end of the 16 weeks of HFD, 
expression of CCL2 and CCL5 remained significantly lower in the eWAT of IP3R1/2AdpCre 
mice than controls while other inflammatory changes subsided (Supp Figure 5F).  
 
Loss of function of IP3R1/2 in adipose tissue protects against insulin resistance 
 
Adipose tissue inflammation is closely associated with insulin resistance. Given the 
impact on IP3R1/2 deletion on decreasing inflammation and stress signaling in adipose 
tissue, we investigated the effect of IP3R1/2 deficiency in tissue and systemic glucose 
metabolism. On a low-fat diet, as with all other parameters measured, IP3R1/2 deletion 
in adipose tissue had no effect on glucose tolerance and insulin sensitivity (Supp Figure 
6A and B). After five weeks of HFD, IP3R1/2AdpCre mice exhibited improved insulin 
sensitivity at the tissue level (Supp Figure 6C), but this was not sufficient to alter glucose 
or insulin tolerance (Supp Figure 6D and E). At later times on HFD (9 weeks), 
IP3R1/2AdpCre mice exhibited improved insulin signaling in eWAT compared to IP3R1/2fl/fl 
mice, as demonstrated by a significant increase in pIR and a trend towards increased 
pAKT (Figure 4G). Accordingly, the IP3R1/2AdpCre mice were more insulin sensitive when 
challenged with an insulin tolerance test (Figure 4H). During an oral glucose tolerance 
test, the glucose excursion curves did not differ between IP3R1/2fl/fl and IP3R1/2AdpCre. 
However, the glucose-induced insulin secretion in IP3R1/2AdpCre mice was significantly 
lower than in control mice (Figure 4I), indicating increased insulin sensitivity. Thus overall, 
adipose tissue-specific loss of function of IP3R1/2 increased diet-induced weight gain but 
protected against adipose tissue inflammation and insulin resistance and fatty liver 
development, thereby representing a metabolically healthy obese phenotype.  
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted October 30, 2020. ; https://doi.org/10.1101/2020.10.28.360008doi: bioRxiv preprint 
Discussion 
 
The discovery of the immunometabolic nature of obesity and the central role of metabolic 
inflammation in adipose tissue dysfunction in obesity and diabetes have been followed 
up by a large amount of research connecting the immune response to metabolism and 
metabolic disease(1, 5, 20, 24, 25). However, the exact molecular events linking obesity-
driven intracellular stress to the development and propagation of inflammation and 
subsequent metabolic pathologies have remained elusive and complex. Here, we show 
that dysregulation of intracellular Ca2+ homeostasis is a key, previously unrecognized, 
link integrating these mechanistic processes into a cohesive model of pathogenesis. 
Specifically, we show that inflammation, modelled in cells in vitro or during the course of 
obesity in vivo, leads to enhanced expression and activation of the ER Ca2+ channel IP3R 
in adipocytes, leading to leakage of ER Ca2+ into the cytoplasm and activation of the 
CaMKII, which has important implications in inflammatory signaling and the development 
of insulin resistance.  
 
Interestingly, the cycle of increased IP3R1 expression and activity promoted by 
inflammatory stress and chronic overnutrition is prevented in the absence of JNK1/2, 
suggesting that JNK is a key upstream factor regulating IP3R induced Ca2+ release and 
CaMKII phosphorylation in adipocytes (Figure 4J), which has not been possible to show 
in a metabolic target and in vivo context.  While a previous report suggests that JNK 
regulates IP3R1 expression at a transcription level in a neuronal cell line(26), it is possible 
that JNK also regulates IP3R1 activity through other mechanisms such as post-
translational modification. It is well established that mice harboring JNK deficiency in 
adipose tissue are protected against metabolic disease, even when challenged by a high 
fat diet(27). Our data suggest that this protection may, at least in part, be mediated by 
decreased IP3R-driven Ca2+ release in JNK1/2 deficient adipocytes.  
 
Inhibition of the rise in cytosolic Ca2+, either by downregulation of IP3R expression or 
treatment with a Ca2+ chelator, BAPTA, significantly diminishes the inflammatory 
cascades triggered by TNFa in cultured adipocytes and adipose tissue inflammation and 
immune cell infiltration promoted by HFD in vivo.  An important impact of the attenuation 
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of inflammatory signaling by downregulation of IP3R1/2 or BAPTA treatment was a 
striking rescue of the insulin resistance caused by inflammatory stress in vitro and 
nutritional stress in vivo, implicating regulation of insulin action by cytosolic Ca2+. 
Inhibition of TRPV4, a non-selective Ca2+ channel, has also been reported to reduce 
adipose tissue inflammation(28) and cytosolic Ca2+ has been linked to insulin signaling 
through an CaMKII-P38-ATF6 axis in liver(29). In our model, CaMKII and p38 
phosphorylation were both decreased by IP3R1/2 downregulation in adipose tissue, 
suggesting that the crosstalk between cytosolic Ca2+ and insulin signaling in adipose 
tissue may be mediated by these kinases (Figure 4J). It is possible that other mechanisms 
regulated by Ca2+ contribute to this phenomenon, such as alterations in mitochondrial 
Ca2+ and oxidative stress. Additional work will be necessary to understand how IP3R 
modulation affects mitochondrial Ca2+ levels and function in adipose tissue. 
 
In summary, our work demonstrates that proper regulation of intracellular Ca2+ 
homeostasis is a central process for the maintenance of adipocyte metabolic health, and 
alterations of this fine balance is a signal that leads to adipocyte dysfunction in the context 
of obesity. Together with the fact  that dysregulated IP3R content and activity in the liver 
is involved in altered hepatic glucose production(30–33), the findings demonstrated here 
suggest that imbalanced intracellular Ca2+ at the IP3R level is a major pillar of metabolic 
homeostasis and alterations in its function collectively predispose to overall metabolic 
defects(29–33). Moreover, this mechanism seems to be well conserved across different 
organisms, since in Drosophila loss of function of IP3R(12) and SOCE(13) in the fat body 
leads to increased adiposity. IP3R1/2 deficiency in the adipose tissue, leads to 
development of greater adiposity uncoupled of metabolic complications, possibly 
representing a model of metabolically healthy obesity.  Therefore, our work supports the 
idea that preventing aberrant IP3R activity could be a powerful strategy to rescue 
systemic glucose metabolism and inflammatory stress in obesity. Indeed, 
pharmacological attempts in this direction are being developed such as the use of SERCA 
agonists(34) or azoramide(35), although it remains to be elucidated whether targeting this 
mechanism can safely improve metabolism in humans. 
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Methods: 
General animal care and study design: All in vivo studies were approved by the 
Harvard Medical Area Standing Committee on Animals. Unless stated otherwise, mice 
were maintained from 4-20 weeks of age on a 12-hour-light /12-hour-dark cycle in the 
Harvard T.H. Chan School of Public Health pathogen-free barrier facility with free access 
to water and to a standard laboratory chow diet (PicoLab Mouse Diet 20 #5058, LabDiet). 
The sample size and number of replicates for this study were chosen based on previous 
experiments performed in our lab and others(31, 36). 
Animal models of obesity: Leptin deficient Lepob (ob/ob) mouse:  Wild type, 
heterozygous and Lepob (ob/ob) mice (Stock no. 000632) were purchased from Jackson 
Laboratories at 6-7 weeks of age and used for experimentation between 8-10 weeks of 
age. Diet-induced obesity:  Male C57BL/6J mice were purchased from Jackson 
Laboratories and placed on HFD (D12492: 60% kcal% fat; Research Diets) for up to 20 
weeks. Control mice of the same age were fed with a low-fat diet (PicoLab Mouse Diet 
20 #5053, LabDiet).  
 
IP3R1/2 adipocyte-specific deficient mice: Mice carrying floxed alleles for IP3R1 and 
IP3R2 (Figure 4A) were kindly provided by Dr. Andrew Marks from Columbia University 
Medical Center(37, 38). To generate adipocyte-specific IP3R1/2 deficient mice, IP3R1 
and IP3R2fl/fl mice were bred to C57BL/6J mice expressing CRE recombinase under the 
control of the adiponectin promoter (Adp-Cre, Jax stock #028020). Adp-Cre-mediated 
recombination of floxed IP3R1/2 alleles was detected in genomic DNA by PCR performed 
with the following protocol: 3 minutes at 950C, 35 times repeats of (30 seconds at 950C, 
30 seconds at 600C, 45 seconds at 720C), 3 minutes at 720C and hold at 40C. Products 
of PCR were as follows; IP3R1-WT: 320bp; IP3R1-floxed: 406bp; IP3R2-WT: 248 bp, 
IP3R2-floxed: 394 bp. The genetic background of the mice was determined to be 93-98% 
C57BL/6.  Age-matched littermates were used for the study.  For the high fat diet (HFD) 
studies, mice were placed on HFD (D12492: 60% kcal% fat; Research Diets) from 6 up 
to 20 weeks. The control chow group were switch from (PicoLab Mouse Diet 20 #5058, 
LabDiet) to low-fat chow diet (PicoLab Mouse Diet 20 #5053, LabDiet) at 6 weeks of age 
and remained on this diet the same period than the HFD.  
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JNK1/2 adipocyte-specific deficient mice: Mice carrying floxed alleles for JNK1 and 
JNK2 were generated in Dr. Roger Davis’s laboratory at the Program in Molecular 
Medicine, UMASS Medical School. JNK1/2 wild type mice crossed with mice carrying Cre 
recombinase under the control of Adiponectin promoter was used as controls. JNK1/2 
flox/flox mice crossed with mice carrying Cre recombinase under control of Adiponectin 
promoter was used to delete JNK1/2 specifically in adipocytes.  Age-matched mice were 
used for the study.  For the high fat diet (HFD) studies, mice were placed on HFD for up 
to 16 weeks. LFD was Purina Cat# IsoPro3000 and HFD was Bioserv # S3282. 
 
Mice respiration: Mouse oxygen consumption and carbon dioxide emission were 
measured using a Columbus Instruments Oxymax-Comprehensive Lab Animal 
Monitoring System (CLAMS) system, according to guidelines for measuring energy 
metabolism in mice(39). We measured brown adipose tissue-mediated respiration by 
intrapertoneal injection of the b3 adrenergic receptor-specific agonist, CL316,243 (CL, 
Tocris, 0.5 mg/kg in 0.9 % w/v in NaCl). 
 
Glucose and insulin tolerance tests: Glucose tolerance tests: Mice were administered 
glucose by oral gavage after overnight fasting (lean: 1.5 g kg-1, obese: 0.5-1.0 g kg-1), and 
blood glucose levels were measured throughout 120 minutes as indicated in the figures. 
For insulin tolerance tests, insulin was injected intraperitoneally (0.75-1U/ kg-1) after 6h 
food withdrawal and blood glucose levels were measured throughout 120 minutes as 
indicated in the figures. 
In vivo lipolysis: Mice were injected intraperitoneally with isoproterenol (10mg/kg in 
PBS, Tocris) after 6h food withdrawal. Blood was collected by tail vein throughout 60 
minutes as indicated in the figure. Free fatty acids and glycerol were determined in the 
plasma. 
Cell culture: For all in vitro experiments 3T3-L1 cells (ATCC) were seeded into culture 
dishes at approximately 70% confluence in DMEM with 4.5mM glucose (GIBCO) 
supplemented with 10% bovine calf serum (CCS) and 1% penicillin/streptomycin. For 
differentiation, once the cells reached 100% confluence (2-3 days after seeding), medium 
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was changed to DMEM with 10% fetal bovine serum (FBS) with 1% 
penicillin/streptomycin. After 2 days (day 0), adipocyte differentiation was induced by the 
addition of 500 µM 3-isobutyl-1-methylxanthine (IBMX), 5 µg/ml insulin, 10 µM 
dexamethasone, and 10 µM rosiglitazone. On day 2 medium was switched to DMEM with 
10% FBS and 1% penicillin/streptomycin, 5 µg/ml insulin and 10 µM rosiglitazone. On day 
4, medium was switched to DMEM with 10% FBS and 1% penicillin/streptomycin 
(maintenance medium), and this medium was replaced every other day until day 10, when 
the adipocytes were fully differentiated. The experiments were performed at day 10. 
 
TNFa and BAPTA-AM treatment: Recombinant murine-TNFa (cat number: 315-01A, 
PeproTech) was dissolved in nuclease-free sterile water and diluted according to the 
user’s manual. The main stock was prepared at concentration of 100 ug/mL and aliquoted 
to prevent thawing-refreezing. For all experiments, TNFa was diluted to 4 ng/ml in the 
maintenance medium and added to cells for the period of time described in the 
experiments at 37oC. After TNFa treatment, the medium was removed, wells were 
washed with PBS and the tissue culture plates were frozen in liquid nitrogen. For 
experiments involving BAPTA-AM (cat number: A1076, Sigma-Aldrich), main stocks were 
prepared at 10 mM in DMSO according to user’s manual and diluted to 1 uM or 10 uM in 
maintenance medium. The amount of DMSO in the BAPTA-AM solution was added to 
TNFa-only and control medium treatment mixtures. For TNFa treatment experiments, 
treatment mixtures were prepared as TNFa-only (with DMSO), TNFa with BAPTA-AM, 
BAPTA-AM-only, and control medium (with DMSO). Treatment mixtures were added 
simultaneously, and culture plates were incubated at 370C.  
 
Transfection protocol: For the IP3R1/2/3 and JNK1/2 knockdown experiments, 10-day-
diffentiated adipocytes were transfected with scramble or IP3R1/2/3 siRNA (separately or 
in combination) or JNK1/2 siRNA. For the transfection, cells were trypsinized (0.25% 
trypsin), transferred into 15 ml conical tubes and centrifuged for 10 minutes at 300 rpm at 
40C. The supernatant was removed, and the pellets were diluted in transfection media 
(DMEM, 10%FBS, no penicillin/streptomycin). The adipocytes were counted and seeded 
in 6 or 12-well plates (5x105 cells/well for 6-well plates and 2.5x105 cells/well for 12-well 
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plates; at approximately 70% confluence). Lipofectamine-RNAiMax (Catalog number: 
13778030) and Opti-MEM medium were from Thermo Fisher Scientific; Mouse-siRNAs 
for On-target SMARTpool scrambled-control, ITPR1 (catalog ID: L-040933-00-0005), 
ITPR2 (L-041018-00-0005), ITPR3 (L-065715-01-0005),  Mapk8 (L-040128-00-0005) 
and Mapk9 (L-040134-00) were from Dharmacon. Transfection mixtures were prepared 
following the lipofectamine-RNAiMAX-transfection protocol. The transfection mixture 
(300ul/well for 6-well plate) was added to the wells containing adipocytes, bringing the 
total volume of the wells up to 2.2 ml. The culture plates were incubated in 370C 
incubators for 16 hours. After 16 hours, medium was replaced with maintenance medium 
and plates were incubated until 36 hours after the transfection before performing the 
experiments.  
 
Insulin signaling experiments: 3T3-L1 cells transfected with scrambled or IP3R1/2 
siRNA were treated with 4ng/mL of TNFa for 4 days with or without BAPTA-AM. Media 
was changed every 24-hours. After 96 hours (4 replacements), cells were washed with 
warm (370C) PBS three times. Then, serum-free medium was added into the wells (6-well 
plates) for 6 hours at 370C. Insulin solutions were prepared in serum-free medium (1, 10 
and 100 nM). After 6 hours, the cells were treated with serum-free medium with or without 
3nM insulin solution for 3 minutes. After insulin treatment wells were washed twice with 
cold PBS and frozen in liquid nitrogen.  
 
Total protein extraction and western blotting: Adipose tissues were homogenized in 
cold lysis buffer containing 50 mM Tris-HCl (pH 7.4), 2 mM EGTA, 5 mM EDTA, 30 mM 
NaF, 10 mM Na3VO4, 10 mM Na4P2O7, 40 mM glycerophosphate, 1% NP-40, and 1% 
protease inhibitor cocktail or  RIPA buffer (Cell signaling #9806) supplemented by 1% 
protease inhibitor cocktail. Adipose tissue was homogenized using a polytron in cold lysis 
buffer. Homogenates were placed on ice for 45 minutes and during this time intermittent 
vortexing was performed. The homogenates were centrifuged for 15 minutes at 9000 
rpm to pellet cell debris. The supernatant with the protein lysate was collected and the 
centrifugation was repeated once more. Protein concentrations were determined by BCA. 
Finally, samples were diluted in 5x Laemmli buffer and boiled for 5 minutes 950C. The 
protein lysates were subjected to SDS-polyacrylamide gel electrophoresis, as previously 
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described(31, 35). Membranes were incubated with anti- JNK (Cell signaling #9252), anti-
pAKT-Rabbit Antibody(Ser473) (Cell Signaling #9271), anti-AKT-Rabbit Antibody (Cell 
Signaling #9272),anti-IR (Santa Cruz 711), p-Insulin Receptor Antibody(p-Thy1162/1163) 
(Calbiochem 407707 or Sigma I1783), phospho-CaM KinaseII (Cell Signaling #12716), 
CamKII (pan) (Cell Signaling #3362), pIP3R1 (Cell signaling #3760),  IP3R1 (Bethyl 
Laboratories – A392-158A), IP3R2 (received as a kind gift from Dr Wojcikiewicz, Upstate 
Medical University), purified mouse anti-IP3R3 (BD Transduction Laboratories),  BiP (Cell 
Signaling #3183), Calnexin (Santa Cruz, sc-6465), Adiponectin-Acrp30 (G-17 clone,sc-
26496), b-tubulin (Abcam, ab 21058).  
SVF and adipocyte isolation: Epididymal adipose tissue was collected in PBS, washed 
twice with fresh PBS  and transferred into 10 cm petri-dishes on ice containing enzymatic 
digestion buffer (Krebs-Ringer solution, 2% BSA, Collagenase type-I (1.25mg 
powder/1ml); 4-5 ml/mouse for lean mice and 7-8 ml/ HFD mice). Immediately after, tissue 
was minced using surgical scissors for 5-10 minutes until each piece is smaller than 1 
mm. The mixture of minced adipose tissue and enzymatic digestion buffer was transferred 
into 50 ml conical tube and placed on ice. Once this procedure was completed for each 
mouse, the mixtures were transferred into a shaker and incubated for 45-60 minutes at 
370C at 100 rpm until all adipose tissue fragments were digested completely. Digested 
mixtures were filtered using 200um strainers (pluriStrainer 200 µm (Cell Strainer); Catalog 
ID: 43-50200-03). For adipocyte fraction preparation, the supernatant adipocyte fraction 
was collected and transferred into 15 ml conical tubes which was then brought up to 10 
mL volume by the addition of Krebs-ringer-2%BSA-mixture followed by centrifugation at 
300 rpm for 10 min at 40C. Following centrifugation, supernatant adipose tissue fraction 
was transferred into 1.5 ml tubes, which were then centrifuged at 300 rpm for 10 min. 
Infranatant buffer was then removed, lysis buffer was added, and the protein lysate was 
prepared as described for whole tissue. For stromal-vascular fraction (SVF) preparation, 
the buffer between the supernatant and the pellet was removed and the remaining pellet 
was mixed with PBS and centrifuged at 3000 rpm for 5 minutes at 40C. Following 
centrifugation, the supernatant buffer was removed, lysis buffer was added to the 
remaining pellet and protein lysate was prepared as described for whole tissue. 
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Gene expression analysis. Tissues were homogenized in Trizol (Invitrogen) using 
TissueLyser (Qiagen). To obtain RNA, Trizol homogenates were mixed with chloroform, 
vortexed thoroughly and centrifuged at 12000g for 20 min at 4oC. The top layer was 
transferred to another tube and mixed with isopropanol and centrifuged again at 12000g 
for 20 min at 4oC. The RNA in the precipitate was washed twice with 70% ethanol and 
diluted in RNAse free water. Complementary DNA was synthesized using iScript RT 
Supermix kit (Biorad). Quantitative real-time PCR reactions were performed in duplicates 
or triplicates on a ViiA7 system (Applied Biosystems) using SYBR green and custom 
primer sets or primer sets based on Harvard primer bank. Gene of interest cycle 
thresholds (Cts) were normalized to TBP housekeeping levels by the DDCt. For 
Supplemental figure 3E, mRNA expression was examined by quantitative RT-PCR 
analysis using a Quantstudio machine (ThermoFisher Scientific). TaqMan assays were 
used to quantify IP3R1 (Itpr1, Mm00439907_m1), IP3R2 (Itpr2, Mm00444937_m1), and 
IP3PR3 (Itpr3, Mm01306070_m1) mRNA (ThermoFisher Scientific).  
Cytosolic Ca2+ imaging using Fura-2 AM: Cells were loaded with 4 μM Fura-2AM and 
1 µM Pluronic F-127 in HBSS for ~30 to 60 min at room temperature. Before imaging, the 
cells were washed and kept in a medium containing 10 mM HEPES, 150 mM NaCl, 4 mM 
KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM D-glucose, pH 7.4 for 10 minutes. Ca2+-free 
medium was prepared similarly to the buffer described above, in the absence of CaCl2 
and in the presence of 2 mM EGTA and 3 mM MgCl2. Ratiometric Fura-2AM imaging was 
performed by in a Nikon Ti-S Inverted Microscope alternatively illuminated with 340 and 
380 nm light for 250 ms (Lambda DG-4; Sutter Instrument Co.), using a 20X objective, 
Nikon CFI Super Fluor. Emission light > 510 nm was captured using a Zyla 4.2 sCMOS 
camera (Andor). Both channels were collected every 5 seconds, background corrected 
and analyzed with NIS-Elements software. Images were analyzed in image J. 
Histological analysis: For histological analysis, adipose and liver tissues were fixed in 
10% zinc-formalin for 24 h at room temperature and transferred to 70% ethanol for further 
storage. Tissues were processed, sectioned and stained with hematoxylin and eosin at 
the Dana Farber Rodent Histopathology facility at Harvard Medical School. Hepatic 
steatosis scoring was based on the method described in(40). Adipose tissue inflammation 
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was evaluated subjectively taking into consideration number and size of inflammatory 
infiltrates. The inflammatory foci were given a score between 0-3, where 0 represented 
no inflammation, 1 was moderate, and 3 pronounced was inflammation.  Both the liver 
and adipose tissue were analyzed blindly by 2 independent researchers and by the 
pathologist from the Dana Farber Rodent Histopathology facility. 
 
Statistical Analysis: Statistical significance was assessed using GraphPad Prism 
Version 7. One-way ANOVA (Tukey post-Hoc test) was used for Fig 1D, 2B and 2D. Two-
way ANOVA (Sidak post-Hoc test) was used for Fig 4B, 4H and 4I using. Student’s t-tests 
was used for all other figures. All data is mean ± SEM. 
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Figure 1: Inflammatory stress leads to increased IP3R expression and activity in 
adipocytes. (A) Representative Fura-2AM-based cytosolic Ca2+ measurements in 
differentiated 3T3-L1 adipocytes treated with 50ng/mL TNFa. (B) Left panel: 
representative Fura-2AM-based cytosolic Ca2+ measurements in differentiated 3T3-L1 
pre-treated with 4ng/mL TNFa for 6 hours. ER Ca2+ depletion was stimulated with 50 µM 
of ATP in media with no extracellular Ca2+. Right panel: quantification of Ca2+ peak 
normalized to baseline. n= 405 cells per group, representative of 2 independent 
experiments, **** p<0.0001. (C) Left panel: Immunoblot analysis of protein expression 
and phosphorylation levels in 3T3-L1 adipocytes treated with vehicle or 4ng/mL TNFa for 
48 hours. Right panel: Quantification of the western blots, n=3, representative of 2 
independent experiments, *p=0.016. (D) Left panel: Immunoblot analysis of protein 
expression and phosphorylation levels in 3T3-L1 adipocytes treated with vehicle or 
4ng/mL TNFa for 6,12 and 24 hours. Right panel:  Quantification of the western blots n=3, 
representative of 3 independent experiments, ***p<=0.0004 (6h), **p=0.007 (12h), 
*p=0.012 (24h). (E) Left panel: Immunoblot analysis of protein expression and 
phosphorylation levels in 3T3-L1 adipocytes transfected with scrambled (SCR) or JNK1/2 
siRNA. Cells were treated with 4ng/mL TNFa  or vehicle for 6 and 12 hours. Right panel:  
Quantification of the western blots, n=2, representative of 2 independent experiments. (F) 
Left panel: Immunoblot analysis of protein expression and phosphorylation levels in 3T3-
L1 adipocytes transfected with scrambled (SCR) and JNK1/2 siRNA. Cells were treated 
with 4ng/mL TNFa  or vehicle for 96h (4d). Right panel:  Quantification of the western 
blots, n=3, ** p=0.0012. (G) Left panel: Immunoblot analysis of protein and 
phosphorylation levels in 3T3-L1 adipocytes treated with vehicle or 4ng/mL TNFa for 24 
hours. Right panel: Quantification of the western blots n=3, **p=0.001. (H) Left panel: 
Immunoblot analysis of protein and phosphorylation levels in 3T3-L1 adipocytes treated 
with vehicle or 4ng/mL TNFa for 96 hours (4d). Right panel: Quantification of the western 
blots, n=3, *p=0.025. 
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Figure 2: IP3R suppression or chelation of cytosolic Ca2+ in adipocytes impairs 
TNFa inflammatory and metabolic action. (A) Left panel: Immunoblot analysis of 
protein expression levels in 3T3-L1 adipocytes transfected with scramble (SCR) and 
IP3R1/2/3 siRNA. Right panel: Quantification of the western blots, n=3, **p=0.029 
(IP3R1), **p<0.002 (IP3R2), **p<0.001 (IP3R3). (B) Left panel: Representative Fura-
2AM-based cytosolic Ca2+ measurements in differentiated 3T3-L1 adipocytes transfected 
with scramble (SCR), IP3R1/2 of IP3R1/2/3 siRNA. Ca2+ release was induced with 50µM 
of ATP in a media with no extracellular Ca2+. Right panel: Quantification of the cytosolic 
Ca2+ peak normalized to baseline, n=236 cells for SCR siRNA and 226 cells for IP3R1/2 
and IP3R1/2/3 siRNA. Representative of 2 independent experiments, ****p<0.0001. (C) 
mRNA levels of the indicated genes evaluated by qPCR derived from 3T3-L1 adipocytes 
transfected with scramble (SCR) and IP3R1/2 siRNA and treated with 4ng/mL of TNFa or 
vehicle for 6 hours, n=5, representative of 4 independent experiments. *p<0.014 (CCL2), 
****p<0.0001 (CCL5, 8, iNOS, FasL R), ***p=0.0006 (TNF), *p<0.05 (IL6). (D) mRNA 
levels of the indicated genes evaluated by qPCR derived from 3T3-L1 adipocytes treated 
with 10 and 25 µM of BAPTA-AM and stimulated with 4ng/mL of TNFa or vehicle for 6 
hours, n=4, representative of 2 independent experiments. *p<0.019 (CCL2), ****p<0.0001 
(CCL5), ***p=0.0002, ****p<0.0001(CXCL10), *p<0.02,****p<0.0001(iNOS).(E) 
Immunoblot analysis and quantification of insulin signaling after 3 minutes of 3nM insulin 
treatment in 3T3-L1 adipocytes transfected with SCR and IP3R1/2 siRNA treated with 
vehicle or 4ng/mL of TNFa for 96 hours, n=3, representative of 2 independent 
experiments, * p<0.03.  
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Figure 3: Obesity leads to increased IP3R expression and pCaMKII phosphorylation 
in adipose tissue. (A) Left panel: Immunoblot analysis of protein expression and 
phosphorylation levels in epididymal white adipose tissue (eWAT) from low fat diet (LFD) 
and high fat diet (HFD)-fed mice (16 weeks). Right panel: Quantification of the western 
blots, n=3 for LFD and 4 for HFD, representative of 3 independent experiments. *p<0.017, 
**p< 0.0027, ***p< 0.0006. (B and C) Left panel: Immunoblot analysis of protein 
expression in adipocyte fraction and stromal-vascular fraction (SVF) derived from 
epididymal white adipose tissue (eWAT) from mice fed low fat diet (LFD), n= 3 or high fat 
diet (HFD) for 16 weeks, n=3. Right Panel: Quantification of the western blots n=3 per 
group, representative of 2 independent experiments, **p<0.001. (D) Left panel: 
Immunoblot analysis of protein expression and phosphorylation levels in epididymal white 
adipose tissue (eWAT) of Wt and leptin-deficient (ob/ob) mice. Right panel:  Quantification 
of the western blots n=4 per group, representative of 2 independent experiments, 
*p=0.0009. (E) Immunoblot analysis of protein expression and phosphorylation levels of 
CaMKII in epididymal white adipose tissue (eWAT). Upper panel, low fat diet (LFD) n= 3 
and high fat diet (HFD) for 16 weeks n=4. Lower panel:  Wt and leptin-deficient (ob/ob) 
mice n=4 per group. Right panel:  Quantification of the western blots, *p<0.045. (F) Left 
panel: Immunoblot analysis of protein expression and phosphorylation levels in eWAT 
derived from controls (JNK1/2WT) and adipocyte-specific loss of JNK1/2 (JNK1/2DWAT) fed 
an LFD or HFD for 16 weeks. Right panel: Quantification of the western blots n=3 per 
group, *** p<0.0005 (IP3R1), **p=0.007, ***p=0.0007 (pCaMKII).  In all panels error bars 
denote s.e.m. 
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Figure 4: IP3R1/2 deficiency leads to increased weight gain and decrease adipose 
tissue inflammation (A) Left panel: Immunoblot analysis of protein expression levels 
epididymal white adipose tissue (eWAT) from control (IP3R1/2fl/f mice) and adipocyte-
specific loss of function of IP3R1/2 (IP3R1/2AdpCRE). Animals were fed chow diet. Right 
panel:  Quantification of the western blots, n=3 per group, eWAT: * p<0.01 (IP3R1), 
*p<0.04 (IP3R2) (B) Weight gain curves of control (IP3R1/2fl/f mice) and adipocyte-specific 
loss of function of IP3R1/2 (IP3R1/2AdpCRE) mice on HFD, n=13 for IP3R1/2fl/f and n=15 
for IP3R1/2AdpCRE.Representative of 3 independent cohorts, *p<0.05,** p=0.001. (C) 
DEXA analysis of whole-body fat and lean mass, n= 13 for IP3R1/2fl/f mice and n=15 for 
IP3R1/2AdpCRE, ***p<0.0001. (D) Representative hematoxylin and eosin stained histology 
section derived from epidydimal white adipose tissue (eWAT) from weight matched 
control (IP3R1/2fl/f mice) and adipocyte-specific loss of IP3R1/2 (IP3R1/2AdpCRE) fed on 
HFD for 8-9 weeks. (E) eWAT mRNA levels of the indicated genes evaluated by qPCR 
of control (IP3R1/2fl/f mice) and adipocyte-specific loss of function for IP3R1/2 
(IP3R1/2AdpCRE) mice fed HFD for 8-9 weeks, n= 11 for IP3R1/2 fl/f  and n=6 for 
IP3R1/2AdpCRE *p<0.012 (CCL5), *p<0.007 (CXCL10), *p<0.016 (CCL1), *p<0.04 (CCL6), 
*p<0.015 SAA3. (F) Left panels: Immunoblot analysis of protein expression and 
phosphorylation levels in epididymal white adipose tissue (eWAT) lysates from control 
(IP3R1/2fl/f mice) and adipocyte-specific loss of function of IP3R1/2 (IP3R1/2AdpCRE) fed 
on HFD for 8-9 weeks. Right panel:  Quantification of the western blots, n=7 per group, 
** p<0.04. (G) Left panel: Markers of insulin signaling evaluated by immunoblot analysis 
of total eWAT from animals injected with insulin (0.45 U/kg) through the inferior vena 
cava. Tissues were collected 3 min after injection. Right panel: Quantification of 
phosphorylation levels of indicated proteins normalized to total protein levels, n= 6 for 
IP3R1/2fl/f and n=5 for IP3R1/2AdpCRE * p<0.004, *** p<0.0001. (H) Left panel: Insulin 
tolerance test in control (IP3R1/2fl/f mice) and adipocyte-specific loss of function of 
IP3R1/2 (IP3R1/2AdpCRE) mice fed HFD for 16 weeks, ***p=0.0004. Right panel:  
Quantification of area under the curve, n= 13 for IP3R1/2fl/f and n= 14 for IP3R1/2AdpCRE, 
representative of 2 independent experiments, ** p<0.006. (I) Left panel: Oral glucose 
tolerance test in control (IP3R1/2fl/fl mice) and adipocyte-specific loss of function of 
IP3R1/2 (IP3R1/2AdpCRE) mice fed HFD for 10 weeks, n= 13 for IP3R1/2fl/f and n= 15 for 
IP3R1/2AdpCRE animals, representative of 2 independent experiments. Right panel: Insulin 
levels during the oral glucose tolerance test. *p<0.05 (10min), **p=0.0032 (20min). (J) 
Working model. In all panels error bars denote s.e.m.  
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Supplemental Figure 1: (A) Representative Fura-2AM-based cytosolic Ca2+ 
measurements in 3T3-L1 adipocytes pre-treated with 4ng/mL TNFa or vehicle for 24 
hours. ER Ca2+ depletion was stimulated with 50 µM of ATP in a media without 
extracellular Ca2+. Representative of 2 experiments. (B) qPCR of mRNA levels of IP3R 
and Ryanodine R (Ryr) isoforms in adipose tissue derived from lean (LFD) and HFD-fed 
mice for 6 weeks. Figure show 2^-(DCT) comparing gene of interest CT to TBP (control) 
CT levels. (C) qPCR of mRNA levels of IP3R and Ryanodine R isoforms in 3T3-L1 
adipocytes. Figure show 2^-(DCT) comparing gene of interest CT to TBP (control) CT 
levels. (D) Quantification analysis of the western blots presented in Figure 1D, n=3 for 
each time point. (E) Quantification analysis of the western blots presented in Figure 1F 
(4 days TNFa treatment). 
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Supplemental Figure 2: (A) mRNA levels evaluated by qPCR of the indicated genes in 
3T3-L1 adipocytes transfected with scrambled (SCR) or IP3R1/2/3 siRNA, n=4 per group, 
representative of 4 independent experiments, *** p<0.0001. (B) mRNA levels of the 
indicated genes evaluated by qPCR in 3T3-L1 adipocytes treated with 10 uM of BAPTA-
AM in the presence of vehicle or 4ng/mL of TNFa for 6 hours. n=4, representative of 2 
independent experiments. *p=0.01 (Fas R, IL6), *** p=0.006 (LPSBP), ****p=0.0004, ** 
p=0.04. (C) Immunoblot analysis and quantification of insulin signaling after 3 minutes of 
3nM insulin treatment in 3T3-L1 adipocytes pre-treated with BAPTA-AM in the presence 
vehicle or 4ng/mL of TNFa for 72 hours, n=3. In all panels error bars denote s.e.m.   
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Supplemental Figure 3: (A) mRNA levels of the indicated genes evaluated by qPCR 
derived from eWAT of mice fed with low fat diet (LFD) or high fat diet (HFD) for 26 weeks, 
n=4 for LFD and n=5 for HFD, representative of 2 independent experiments. *p=0.02 
(IP3R1, IP3R3), * p=0.04 (IP3R2). (B) Immunoblot analysis of adiponectin expression in 
stromal vascular fraction (SVF) and adipocyte fraction derived from adipose tissue of 
animals on LFD and HFD.  (C) Quantification of western blot shown in Figure 3F. 
**p=0.004. (D) Left panel: Immunoblot analysis of protein expression and phosphorylation 
levels in eWAT derived from controls (JNK1/2WT) and adipocyte-specific loss of JNK1/2 
(JNK1/2DWAT) fed LFD or HFD for 16 weeks. Right panel: Quantification of the western 
blots, n=4 per group, * p<0.01 (IP3R1), *p=0.02, ***p=0.0003 (JNK1/2).  (E) mRNA levels 
of the indicated genes evaluated by qPCR derived from controls (JNK1/2WT) and 
adipocyte-specific loss of JNK1/2 (JNK1/2DWAT) fed LFD or HFD for 16 weeks. n=7 for 
JNK1/2WT (LFD and HFD) and n=8 for JNK1/2DWAT (LFD and HFD), **p=0.001 (IP3R1), 
*p=0.01, ** p=0.0029 (IP3R2). In all panels error bars denote s.e.m. 
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Supplemental Figure 4: (A) Schematic representation of the animal breeding scheme to 
obtain mice with adipocyte specific IP3R1/2 deletion. (B) Immunoblot analysis of protein 
expression levels in brown adipose tissue (BAT) from control (IP3R1/2fl/fl mice) and 
adipocyte-specific loss of function of IP3R1/2 (IP3R1/2AdpCRE) mice on chow diet. Right 
panel: Quantification of the western blots, n=3 per group, *p<0.042. (C) mRNA levels of 
the indicated genes evaluated by qPCR from brown adipose tissue (BAT) (upper panel) 
and white epididymal adipose tissue (eWAT) (lower panel) from control (IP3R1/2fl/fl) and 
adipocyte-specific loss of function for IP3R1/2 (IP3R1/2AdpCRE). BAT: n=9 per group, 
eWAT: n=8 for IP3R1/2fl/f and n=6 for IP3R1/2AdpCRE. (D) Weight gain curves of control 
(IP3R1/2 fl/fl) and adipocyte-specific loss of function of IP3R1/2 (IP3R1/2AdpCRE) mice on 
low fat diet, n=10 for IP3R1/2 fl/fl and n=9 IP3R1/2AdpCRE, representative of 3 independent 
cohorts. (E) Oxygen consumption rates (VO2) measured in metabolic cages in control 
(IP3R1/2 fl/fl mice) and adipocyte specific loss of function of IP3R1/2 (IP3R1/2AdpCRE) mice 
on HFD for 8-9 weeks. n= 7 IP3R1/2 fl/f   and n=8 IP3R1/2AdpCRE per group. (F) Carbon 
dioxide production rates (VCO2) measured in metabolic cages in control (IP3R1/2fl/fl) and 
adipocyte specific loss of function for IP3R1/2 (IP3R1/2AdpCRE) on HFD for 8-9 weeks. n= 
7 for IP3R1/2fl/fl and n=8 for IP3R1/2AdpCRE. (G) Body weights of the mice presented in E 
and F. (H) Daily food intake measured during 5 consecutive days in food for control 
(IP3R1/2fl/fl) and adipocyte-specific loss of function of IP3R1/2 (IP3R1/2AdpCRE) on HFD 
for 8-9 weeks. n= 8 per group. (I) Plasma non-esterified free fatty acid (J) Plasma glycerol 
levels after 6 hours fasting (0 min) and at 15, 30 and 60 minutes after isoproterenol 
injection (ISO) in control (IP3R1/2fl/fl) and adipocyte specific loss of function for IP3R1/2 
(IP3R1/2AdpCRE) mice fed on HFD for 6 weeks, n= 8 for IP3R1/2fl/fl and n=5 for 
IP3R1/2AdpCRE.  
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Supplemental Figure 5: (A) Representative hematoxylin and eosin stained histology 
section from epidydimal white adipose tissue (eWAT) of control (IP3R1/2fl/f) and 
adipocyte- specific loss of function of IP3R1/2 (IP3R1/2AdpCRE) mice fed low fat diet. (B) 
Scoring of the degree of inflammatory cell infiltration in the tissue. 1- normal or low 
steatitis, 2- medium steatitis, 3-high steatitis. (C) mRNA levels of the indicated genes 
evaluated by qPCR derived from eWAT of control (IP3R1/2fl/f mice) and adipocyte-specific 
loss of function of IP3R1/2 (IP3R1/2AdpCRE) mice fed HFD for 8 weeks. (D) Left panel: 
Representative hematoxylin and eosin stained histology sections from liver of weight-
matched control (IP3R1/2fl/fl) and adipocyte specific loss of function for IP3R1/2 
(IP3R1/2AdpCRE) mice fed on HFD for 8-9 weeks, n=11 for IP3R1/2 fl/fl and n=6 for 
IP3R1/2AdpCRE. Right panel: Scoring of the degree of hepatosteatosis. 0= normal, 1- low 
hepatosteatosis, 2- medium hepatosteatosis, 3-high hepatosteatosis. (E) Left panel: 
Immunoblot analysis of protein expression and phosphorylation levels in epididymal white 
adipose tissue (eWAT) from control (IP3R1/2fl/fl) and adipocyte-specific loss of function of 
IP3R1/2 (IP3R1/2AdpCRE) mice fed on HFD for 8-9 weeks. Right panel:  Quantification of 
the western blots, n=7 per group. *** p<0.001 (F) mRNA levels of the indicated genes 
evaluated by qPCR derived from eWAT of control (IP3R1/2fl/fl) and adipocyte-specific loss 
of function of IP3R1/2 (IP3R1/2AdpCRE) mice fed on HFD for 16 weeks, n= 13 for IP3R1/2fl/fl 
and 15 for IP3R1/2AdpCRE , * p<0.017, ****p<0.0001.    
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Supplemental Figure 6: (A) Oral glucose tolerance test in control (IP3R1/2 fl/fl) and 
adipocyte-specific loss of function of IP3R1/2 (IP3R1/2AdpCRE) fed low fat diet (LFD), n=10 
for IP3R1/2fl/fl and n=9 IP3R1/2AdpCRE.(B) Insulin tolerance test in control (IP3R1/2fl/fl ) and 
adipocyte-specific loss of function of IP3R1/2 (IP3R1/2AdpCRE) mice fed on low fat diet 
(LFD), n=10 for IP3R1/2 fl/fl and n=9 for IP3R1/2AdpCRE  (C) Upper panel: Markers of in 
vivo insulin signaling evaluated by immunoblot analysis of total eWAT from animals 
injected with insulin (0.45 U/kg) through the inferior vena cava. Tissues were collected 3 
min after injection. Lower panel: phospho-protein level quantification normalized to total 
protein levels. n= 6 for IP3R1/2fl/fl and n=5 for IP3R1/2AdpCRE. (D) Intra-peritoneal glucose 
tolerance test in control (IP3R1/2fl/fl) and adipocyte specific loss of function of IP3R1/2 
(IP3R1/2AdpCRE) mice fed high fat diet (HFD) for 4 weeks, n=9 for IP3R1/2fl/fl and n=10 for 
IP3R1/2AdpCRE. (E) Insulin tolerance test in control (IP3R1/2fl/fl) and adipocyte-specific loss 
of function of IP3R1/2 (IP3R1/2AdpCRE) mice fed HFD for 5 weeks, n=9 for IP3R1/2fl/fl and 
n=10 for IP3R1/2AdpCRE.  
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